Gut Microbiota and Immunotherapy

Exploring how gut microbiota influences the effectiveness of immunotherapy and overall health

Free cancer support
The Hong Kong Cancer Support Network provides you with comprehensive, free cancer information and professional assistance, ensuring that every patient and family member does not have to face the challenge alone.

Gut Microbiota and the Immune System

The gut microbiota is a key regulator of the human immune system. The intestinal mucosal barrier not only prevents harmful substances from entering the body but also maintains overall health through microbial and immune balance.

Role of Probiotics

Probiotics help preserve gut integrity, suppress harmful pathogens, improve nutrient absorption, and regulate immune responses.

  • Lactobacillus and Bifidobacterium are particularly effective in preventing and alleviating inflammatory bowel conditions.

Chemotherapy and Gut Health

Chemotherapy can disrupt microbial diversity, leading to side effects such as diarrhea, fatigue, and weakened immunity.

  • Probiotics and fecal microbiota transplantation (FMT) have shown potential in restoring gut balance and reducing complications.

Gut Microbiota and Immunotherapy

The success of immunotherapy, particularly PD-1 and CTLA-4 checkpoint inhibitors, is closely linked to gut microbiome diversity.

  • Studies show that specific beneficial bacteria can enhance response rates and prolong progression-free survival in cancer patients undergoing immunotherapy.

Supporting Gut Health in Cancer Patients

  • Dietary diversity: A wide range of vegetables, fruits, whole grains, prebiotics, and fermented foods supports healthy microbiota.
  • Probiotics and prebiotics: May strengthen the gut barrier and immune response.
  • FMT: Emerging evidence suggests fecal transplantation may become an important adjunct in cancer immunotherapy.

Conclusion

Gut microbiota is not only essential for digestion but also plays a critical role in cancer outcomes. By maintaining gut health through diet, probiotics, and lifestyle interventions, cancer patients may enhance the effectiveness of immunotherapy and improve overall well-being.

Contact our professional team now

References

  • Gopalakrishnan, V., Spencer, C. N., Nezi, L., et al. (2018). Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients. Science, 359(6371), 97–103.
  • Routy, B., Le Chatelier, E., Derosa, L., et al. (2018). Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science, 359(6371), 91–97.
  • Zitvogel, L., Ma, Y., Raoult, D., Kroemer, G., & Gajewski, T. F. (2018). The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science, 359(6382), 1366–1370.
Scroll to Top